• OPEN AN ACCOUNT
Indian Indices
Sensex
71,909.70 -570.59
( -0.79%)
Global Indices
Nasdaq
50,952.25 25.20
(0.05%)
Dow Jones
7,687.74 15.20
(0.20%)
Hang Seng
68,256.51 -700.21
(-1.02%)
Nikkei 225
10,455.36 27.09
(0.26%)
Forex
USD-INR
95.92 -0.05
(-0.05%)
EUR-INR
108.79 -0.10
(-0.09%)
GBP-INR
127.19 0.21
(0.17%)
JPY-INR
0.61 0.00
(0.14%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
337.9869392
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
44.44
44762.82
EPS(TTM)
Face Value()
Div & Yield %
80.61
2
0.78
 

Board of Dr. Lal PathLabs recommends interim dividend
Jul 24,2026
Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held on 24 July 2026, inter alia, have recommended the interim dividend of Rs 5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.